These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 19562219)
61. Biodegradable polyalkylcyanoacrylate nanoparticles for the delivery of oligonucleotides. Fattal E; Vauthier C; Aynie I; Nakada Y; Lambert G; Malvy C; Couvreur P J Control Release; 1998 Apr; 53(1-3):137-43. PubMed ID: 9741921 [TBL] [Abstract][Full Text] [Related]
62. Qualitative and quantitative measurements of oligonucleotides in gene therapy: Part II in vivo models. Tewary HK; Iversen PL J Pharm Biomed Anal; 1997 May; 15(8):1127-35. PubMed ID: 9215965 [TBL] [Abstract][Full Text] [Related]
63. Nanoparticle-Patterned Multicompartmental Chitosan Capsules for Oral Delivery of Oligonucleotides. Kim T; Kim JU; Yang K; Nam K; Choe D; Kim E; Hong IH; Song M; Lee H; Park J; Roh YH ACS Biomater Sci Eng; 2018 Dec; 4(12):4163-4173. PubMed ID: 33418815 [TBL] [Abstract][Full Text] [Related]
64. Reliable assessment and quantification of the fluorescence-labeled antisense oligonucleotides in vivo. Munisso MC; Yamaoka T Biomed Res Int; 2014; 2014():196837. PubMed ID: 24967340 [TBL] [Abstract][Full Text] [Related]
65. Qualitative and quantitative measurements of oligonucleotides in gene therapy: Part I. In vitro models. Tewary HK; Iversen PL J Pharm Biomed Anal; 1997 Apr; 15(7):857-73. PubMed ID: 9160252 [TBL] [Abstract][Full Text] [Related]
66. Protein Microspheres with Unique Green and Red Autofluorescence for Noninvasively Tracking and Modeling Their in Vivo Biodegradation. Ma X; Wang T; Song D; Hargrove D; Dong Q; Luo Z; Chen J; Lu X; Luo Y; Fan TH; Lei Y ACS Biomater Sci Eng; 2016 Jun; 2(6):954-962. PubMed ID: 33429505 [TBL] [Abstract][Full Text] [Related]
68. Studies of DNA Aptamer OliGreen and PicoGreen Fluorescence Interactions in Buffer and Serum. Bruno JG; Sivils JC J Fluoresc; 2016 Jul; 26(4):1479-87. PubMed ID: 27209004 [TBL] [Abstract][Full Text] [Related]
69. Liposome-encapsulated polyethylenimine/oligonucleotide polyplexes prepared by reverse-phase evaporation technique. Ko YT; Bickel U AAPS PharmSciTech; 2012 Jun; 13(2):373-8. PubMed ID: 22328240 [TBL] [Abstract][Full Text] [Related]
70. Nanoparticulate systems for the delivery of antisense oligonucleotides. Lambert G; Fattal E; Couvreur P Adv Drug Deliv Rev; 2001 Mar; 47(1):99-112. PubMed ID: 11251248 [TBL] [Abstract][Full Text] [Related]
71. Formulation and in vitro characterization of spray-dried antisense oligonucleotide to NF-kappaB encapsulated albumin microspheres. Gayakwad SG; Bejugam NK; Akhavein N; Uddin NA; Oettinger CE; D'Souza MJ J Microencapsul; 2009 Dec; 26(8):692-700. PubMed ID: 19888878 [TBL] [Abstract][Full Text] [Related]
73. Enhanced intracellular uptake and inhibition of NF-kappaB activation by decoy oligonucleotide released from PLGA microspheres. De Rosa G; Maiuri MC; Ungaro F; De Stefano D; Quaglia F; La Rotonda MI; Carnuccio R J Gene Med; 2005 Jun; 7(6):771-81. PubMed ID: 15702489 [TBL] [Abstract][Full Text] [Related]
74. pH-sensitive and mucoadhesive thiolated Eudragit-coated chitosan microspheres. Quan JS; Jiang HL; Kim EM; Jeong HJ; Choi YJ; Guo DD; Yoo MK; Lee HG; Cho CS Int J Pharm; 2008 Jul; 359(1-2):205-10. PubMed ID: 18490120 [TBL] [Abstract][Full Text] [Related]
75. A methodology for quantitation and characterization of oligonucleotides in albumin microspheres. Uddin MN; Do DP; Pai SB; Gayakwad S; Oettinger CW; D'Souza MJ Analyst; 2009 Jul; 134(7):1483-9. PubMed ID: 19562219 [TBL] [Abstract][Full Text] [Related]